Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | -0.81% | -0.81% | -18.00% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 111M |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -100M | EV / Sales 2024 * | - |
Net cash position 2024 * | 33.12M | Net Debt 2025 * | 55.55M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.24
x | P/E ratio 2025 * |
-1.4
x | Employees | 80 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.28% |
Latest transcript on Immunic, Inc.
1 day | -0.81% | ||
1 week | -0.81% | ||
Current month | -0.81% | ||
1 month | -10.87% | ||
3 months | -15.75% | ||
Current year | -18.00% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 16-12-31 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19-11-18 |
Tamar Howson
BRD | Director/Board Member | 75 | 19-10-10 |
Jörg Neermann
BRD | Director/Board Member | 57 | 19-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.23 | -0.81% | 100,324 |
24-06-06 | 1.24 | -0.80% | 100,356 |
24-06-05 | 1.25 | +3.31% | 104,030 |
24-06-04 | 1.21 | -4.72% | 169,211 |
24-06-03 | 1.27 | +2.42% | 183,657 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.00% | 111M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- IMUX Stock